Decoy Therapeutics, Inc. (DCOY)
2.90
-0.07
(-2.36%)
USD |
NASDAQ |
Aug 28, 16:00
2.86
-0.04
(-1.38%)
After-Hours: 20:00
Decoy Therapeutics Total Return Price : 2.90 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 28, 2026 | 2.90 |
| August 27, 2026 | 2.97 |
| August 26, 2026 | 3.01 |
| August 25, 2026 | 2.98 |
| August 24, 2026 | 3.11 |
| August 21, 2026 | 3.20 |
| August 20, 2026 | 3.28 |
| August 19, 2026 | 3.41 |
| August 18, 2026 | 3.67 |
| August 17, 2026 | 3.52 |
| August 14, 2026 | 3.58 |
| August 13, 2026 | 3.53 |
| August 12, 2026 | 3.60 |
| August 11, 2026 | 3.87 |
| August 10, 2026 | 3.83 |
| August 07, 2026 | 3.93 |
| August 06, 2026 | 4.06 |
| August 05, 2026 | 4.19 |
| August 04, 2026 | 4.37 |
| August 03, 2026 | 4.34 |
| July 31, 2026 | 4.11 |
| July 30, 2026 | 3.92 |
| July 29, 2026 | 4.03 |
| July 28, 2026 | 4.04 |
| July 27, 2026 | 3.74 |
| Date | Value |
|---|---|
| July 24, 2026 | 5.04 |
| July 23, 2026 | 4.94 |
| July 22, 2026 | 4.95 |
| July 21, 2026 | 4.92 |
| July 20, 2026 | 5.305 |
| July 17, 2026 | 5.61 |
| July 16, 2026 | 5.99 |
| July 15, 2026 | 6.18 |
| July 14, 2026 | 5.75 |
| July 13, 2026 | 5.84 |
| July 10, 2026 | 5.91 |
| July 09, 2026 | 6.265 |
| July 08, 2026 | 5.75 |
| July 07, 2026 | 7.02 |
| July 06, 2026 | 7.25 |
| July 02, 2026 | 7.31 |
| July 01, 2026 | 7.62 |
| June 30, 2026 | 7.19 |
| June 29, 2026 | 9.59 |
| June 26, 2026 | 5.518 |
| June 25, 2026 | 5.918 |
| June 24, 2026 | 6.11 |
| June 23, 2026 | 6.00 |
| June 22, 2026 | 6.30 |
| June 18, 2026 | 6.07 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Palatin Technologies, Inc. | 10.48 |
| Unicycive Therapeutics, Inc. | 5.265 |
| Nuvectis Pharma, Inc. | 23.73 |
| ACADIA Pharmaceuticals, Inc. | 29.11 |
| Alnylam Pharmaceuticals, Inc. | 237.10 |